Literature DB >> 10463664

Acceleration of viral replication and up-regulation of cytokine levels by antimalarials: implications in malaria-endemic areas.

P Seth1, H Mani, A K Singh, K K Banaudha, S Madhavan, G S Sidhu, J P Gaddipati, S N Vogel, R K Maheshwari.   

Abstract

Antimalarial drugs are widely used in malaria endemic areas, both for chemoprophylaxis and also empirically to treat patients presenting with fever. Previously, we have reported that chloroquine enhances the severity of Semliki forest virus (SFV) and encephalomyocarditis virus infection. The studies presented herein show that a broad spectrum of antimalarial drugs augmented the replication of SFV in mice, concomitant with greater tissue damage and up-regulation of mRNA levels of various inflammatory cytokine genes, including interleukin-1 receptor antagonist (IL-1Ra), II-1alpha, IL-1beta, IL-6, IL-12p40, and interferon-gamma inducing factor. Furthermore, chloroquine enhances IL-1Ra production in RAW cells in vitro. Since IL-1Ra is known to be up-regulated in a number of viral infections, we propose that a further enhancement of its expression by antimalarials may be responsible for the increased severity of viral infection in our studies. Thus, the widespread use of antimalarials in malaria-endemic areas may predispose the population to viral infections. Further studies are in progress to delineate mechanism(s) involved in cytokine up-regulation and acceleration of viral replication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463664     DOI: 10.4269/ajtmh.1999.61.180

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Chloroquine mediated molecular tuning of astrocytes for enhanced permissiveness to HIV infection.

Authors:  Theophilus S Vijaykumar; Avindra Nath; Ashok Chauhan
Journal:  Virology       Date:  2008-09-11       Impact factor: 3.616

2.  Chikungunya disease and chloroquine treatment.

Authors:  Ilenia Delogu; Xavier de Lamballerie
Journal:  J Med Virol       Date:  2011-06       Impact factor: 2.327

3.  Chloroquine paradox may cause more damage than help fight COVID-19.

Authors:  Anuj Sharma
Journal:  Microbes Infect       Date:  2020-04-17       Impact factor: 2.700

4.  Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents.

Authors:  Elmeri M Jokinen; Krishnasamy Gopinath; Sami T Kurkinen; Olli T Pentikainen
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2021-08-06       Impact factor: 3.702

Review 5.  Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.

Authors:  Bogna Grygiel-Górniak
Journal:  Clin Rheumatol       Date:  2021-07-03       Impact factor: 3.650

6.  Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis.

Authors:  Gilmara Franco da Cunha; Fernando Henrique Carlos de Souza; Maurício Levy-Neto; Samuel Katsuyuki Shinjo
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

7.  Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.

Authors:  Pierre Roques; Simon-Djamel Thiberville; Laurence Dupuis-Maguiraga; Fok-Moon Lum; Karine Labadie; Frédéric Martinon; Gabriel Gras; Pierre Lebon; Lisa F P Ng; Xavier de Lamballerie; Roger Le Grand
Journal:  Viruses       Date:  2018-05-17       Impact factor: 5.048

8.  Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Authors:  Awadhesh Kumar Singh; Akriti Singh; Altamash Shaikh; Ritu Singh; Anoop Misra
Journal:  Diabetes Metab Syndr       Date:  2020-03-26

9.  Chloroquine commonly induces hormetic dose responses.

Authors:  Edward J Calabrese; Jaap C Hanekamp; Yannic N Hanekamp; Rachna Kapoor; Gaurav Dhawan; Evgenios Agathokleous
Journal:  Sci Total Environ       Date:  2020-09-25       Impact factor: 7.963

10.  Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease.

Authors:  Jihad Mallat; Fadi Hamed; Maher Balkis; Mohamed A Mohamed; Mohamad Mooty; Asim Malik; Ahmad Nusair; Maria-Fernanda Bonilla
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.